Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Igen up on Roche talks

Diagnostics company IGEN was up $4.70 (14%) to $39.10 on 4

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE